This reduction in the eosinophil count might be due (at least in part) to the inhibition of CCL5 release in bronchial explants (as seen in the present study), which might contribute to the reduction in moderate-to-severe exacerbations of COPD (Martinez et al., 2018). Here, CCL5 is linked to chronic obstructive pulmonary disease.